Genetics and pharmacogenetics of substance use disorders

Pao-Luh Tao ^a,*, Li-Shiun Chen ^b, Chih-Ken Chen ^c, Yu-Li Liu ^a

a Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan, ROC
b Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
c Department of Psychiatry, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC

The “Genetics and pharmacogenetics of substance use disorder” session was chaired by Dr Pao-Luh Tao and had three speakers. The speakers and topics were as follows. Dr Li-Shiun Chen discussed “Genomics and personalized medicine for smoking cessation treatments”. Dr Chih-Ken Chen presented a talk on the “Genetics of methamphetamine abuse and methamphetamine psychosis”. Dr Yu-Li Liu described a “Pharmacogenomics study in a Taiwan methadone maintenance cohort”.

Keywords:Genetics, Methadone, Methamphetamine, Pharmacogenetics, Smoking cessation, Substance use disorders